O	0	10	Assessment
O	11	13	of
O	14	15	a
B-intervention	16	25	guideline
I-intervention	25	26	-
I-intervention	26	31	based
I-intervention	32	37	heart
I-intervention	38	51	substructures
I-intervention	52	63	delineation
O	64	66	in
B-eligibility	67	71	left
I-eligibility	71	72	-
I-eligibility	72	77	sided
I-eligibility	78	84	breast
I-eligibility	85	91	cancer
I-eligibility	92	100	patients
I-eligibility	101	111	undergoing
I-eligibility	112	120	adjuvant
I-eligibility	121	133	radiotherapy
O	134	135	:
O	136	143	Quality
O	144	154	assessment
O	155	161	within
O	162	163	a
O	164	174	randomized
O	175	180	phase
O	181	184	III
O	185	190	trial
O	191	198	testing
O	199	200	a
O	201	217	cardioprotective
O	218	227	treatment
O	228	236	strategy
O	237	238	(
O	238	242	SAFE
O	242	243	-
O	243	247	2014
O	247	248	)
O	248	249	.

O	250	252	In
O	253	256	our
O	257	266	institute
O	266	267	,
O	268	274	breast
O	275	281	cancer
O	282	290	patients
O	291	301	undergoing
O	302	310	adjuvant
O	311	320	treatment
O	321	324	are
O	325	333	included
O	334	336	in
O	337	338	a
O	339	347	protocol
O	348	353	aimed
O	354	356	to
O	357	363	reduce
B-condition	364	378	cardiovascular
I-condition	379	388	morbidity
O	389	390	(
O	390	394	SAFE
O	394	395	-
O	395	399	2014
O	399	400	,
O	401	411	NCT2236806
O	411	412	)
O	412	413	,
O	414	423	assessing
O	424	435	preclinical
O	436	441	heart
O	442	448	damage
O	449	453	with
O	454	459	heart
O	460	467	speckle
O	467	468	-
O	468	476	tracking
O	477	487	ultrasound
O	487	488	.

O	489	491	To
O	492	499	develop
O	500	501	a
O	502	506	dose
O	507	517	constraint
O	518	525	related
O	526	528	to
O	529	540	subclinical
O	541	546	heart
O	547	553	damage
O	553	554	,
O	555	556	a
O	557	565	reliable
O	566	577	delineation
O	578	580	of
O	581	586	heart
O	587	600	substructures
O	601	606	based
O	607	609	on
O	610	611	a
O	612	615	pre
O	615	616	-
O	616	624	existing
O	625	634	guideline
O	635	638	was
O	639	643	made
O	643	644	.

O	645	650	Heart
O	651	664	substructures
O	665	667	of
B-total-participants	668	670	16
O	671	675	left
O	675	676	-
O	676	681	sided
O	682	688	breast
O	689	695	cancer
O	696	704	patients
O	705	713	included
O	714	716	in
O	717	720	the
O	721	725	SAFE
O	726	734	protocol
O	735	739	were
O	740	750	delineated
O	751	753	by
O	754	758	five
O	759	768	operators
O	768	769	.

O	770	773	For
O	774	778	each
O	779	791	substructure
O	791	792	,
O	793	794	a
O	795	800	multi
O	800	801	-
O	801	808	contour
O	809	820	delineation
O	821	826	based
O	827	829	on
O	830	831	a
O	832	840	majority
O	841	845	vote
O	846	855	algorithm
O	856	857	(
O	857	860	MCD
O	860	861	)
O	862	865	was
O	866	873	created
O	873	874	.

O	875	876	A
O	877	886	consensus
O	886	887	-
O	887	892	based
O	893	904	delineation
O	905	906	(
O	906	909	CBD
O	909	910	)
O	911	914	was
O	915	924	developed
O	925	927	by
O	928	930	an
O	931	942	independent
O	943	947	team
O	948	950	of
O	951	954	two
O	955	962	blinded
O	963	972	operators
O	972	973	.

O	974	978	Dice
O	979	989	similarity
O	990	1002	coefficients
O	1003	1004	(
O	1004	1007	DSC
O	1007	1008	)
O	1009	1016	between
O	1017	1024	volumes
O	1025	1035	delineated
O	1036	1038	by
O	1039	1048	different
O	1049	1058	operators
O	1059	1062	and
O	1063	1066	the
O	1067	1070	MCD
O	1071	1075	were
O	1076	1085	collected
O	1086	1089	and
O	1090	1098	reported
O	1098	1099	,
O	1100	1102	as
O	1103	1107	well
O	1108	1110	as
O	1111	1114	DSC
O	1115	1122	between
O	1123	1126	CBD
O	1127	1130	and
O	1131	1134	MCD
O	1134	1135	.

B-outcome	1136	1140	Mean
I-outcome	1141	1145	DSCs
I-outcome	1146	1153	between
I-outcome	1154	1159	heart
I-outcome	1160	1168	chambers
O	1169	1179	delineated
O	1180	1182	by
O	1183	1187	each
O	1188	1196	operator
O	1197	1200	and
O	1201	1204	the
O	1205	1218	corresponding
O	1219	1223	MCDs
O	1224	1230	ranged
O	1231	1238	between
O	1239	1240	0
O	1240	1241	.
O	1241	1243	78
O	1244	1247	and
O	1248	1249	0
O	1249	1250	.
O	1250	1252	96
O	1252	1253	.

B-outcome	1254	1258	Mean
I-outcome	1259	1262	DSC
I-outcome	1263	1270	between
I-outcome	1271	1284	substructures
O	1285	1295	delineated
O	1296	1298	by
O	1299	1302	all
O	1303	1309	single
O	1310	1319	operators
O	1320	1323	and
O	1324	1327	the
O	1328	1341	corresponding
O	1342	1345	MCD
O	1346	1352	ranged
O	1353	1360	between
O	1361	1362	0
O	1362	1363	.
O	1363	1365	84
O	1366	1369	and
O	1370	1371	0
O	1371	1372	.
O	1372	1374	94
O	1374	1375	.

B-outcome	1376	1380	Mean
I-outcome	1381	1384	DSC
I-outcome	1385	1392	between
I-outcome	1393	1396	CBD
I-outcome	1397	1400	and
I-outcome	1401	1404	the
I-outcome	1405	1418	corresponding
I-outcome	1419	1422	MCD
O	1423	1429	ranged
O	1430	1434	from
O	1435	1436	0
O	1436	1437	.
O	1437	1439	89
O	1440	1442	to
O	1443	1444	0
O	1444	1445	.
O	1445	1447	97
O	1447	1448	.

O	1449	1456	Results
O	1457	1463	showed
O	1464	1467	low
O	1468	1473	inter
O	1473	1474	-
O	1474	1482	observer
O	1483	1494	variability
O	1495	1497	of
O	1498	1503	heart
O	1504	1516	substructure
O	1517	1528	delineation
O	1528	1529	.

O	1530	1534	This
O	1535	1546	constitutes
O	1547	1549	an
O	1550	1558	external
O	1559	1569	validation
O	1570	1572	of
O	1573	1576	the
O	1577	1587	contouring
O	1588	1593	atlas
O	1594	1598	used
O	1598	1599	,
O	1600	1608	allowing
O	1609	1610	a
O	1611	1619	reliable
O	1620	1630	dosimetric
O	1631	1641	assessment
O	1642	1644	of
O	1645	1650	these
O	1651	1658	volumes
O	1659	1665	within
O	1666	1669	the
O	1670	1674	SAFE
O	1674	1675	-
O	1675	1679	2014
O	1680	1685	trial
O	1685	1686	.
